Deborah Wong, MD, PhD, discusses the toripalimab combination that is now considered standard of care in nasopharyngeal cancer.
Deborah Wong, MD, PhD
Deborah Wong, MD, PhD, is an associate clinical professor in the Department of Medicine, Division of Hematology-Oncology and director of the Head and Neck Medical Oncology Program at the University of California, Los Angeles.
Articles by Deborah Wong, MD, PhD
Deborah Wong, MD, PhD, discusses therapeutic options for patients with nasopharyngeal carcinoma.